Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis
- PMID: 26314731
- PMCID: PMC4751087
- DOI: 10.1016/j.schres.2015.08.004
Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis
Abstract
Background: Despite advances that the psychosis "clinical high-risk" (CHR) identification offers, risk of stigma exists. Awareness of and agreement with stereotypes has not yet been evaluated in CHR individuals. Furthermore, the relative stigma associated with symptoms, as opposed to the label of risk, is not known, which is critical because CHR identification may reduce symptom-related stigma.
Methods: Thirty-eight CHR subjects were ascertained using standard measures from the Center of Prevention and Evaluation/New York State Psychiatric Institute/ Columbia University. Labeling-related measures adapted to the CHR group included "stereotype awareness and self-stigma" ("Stereotype awareness", "Stereotype Agreement", "Negative emotions [shame]"), and a parallel measure of "Negative emotions (shame)" for symptoms. These measures were examined in relation to symptoms of anxiety and depression, adjusting for core CHR symptoms (e.g. attenuated psychotic symptoms).
Results: CHR participants endorsed awareness of mental illness stereotypes, but largely did not themselves agree with these stereotypes. Furthermore, CHR participants described more stigma associated with symptoms than they did with the risk-label itself. Shame related to symptoms was associated with depression, while shame related to the risk-label was associated with anxiety.
Conclusion: Both stigma of the risk-label and of symptoms contribute to the experience of CHR individuals. Stereotype awareness was relatively high and labeling-related shame was associated with increased anxiety. Yet limited agreement with stereotypes indicated that labeling-related stigma had not fully permeated self-conceptions. Furthermore, symptom-related stigma appeared more salient overall and was linked with increased depression, suggesting that alleviating symptom-related shame via treating symptoms might provide major benefit.
Keywords: Adolescents; At risk; Clinical high risk state for psychosis; Discrimination; Early psychosis; Prodrome; Stigma.
Copyright © 2015. Published by Elsevier B.V.
Conflict of interest statement
Conflict of interest
All authors declare that they have no conflicts of interest.
Similar articles
-
Well-being among persons at risk of psychosis: the role of self-labeling, shame, and stigma stress.Psychiatr Serv. 2014 Apr 1;65(4):483-9. doi: 10.1176/appi.ps.201300169. Psychiatr Serv. 2014. PMID: 24382666
-
Clinical high risk for psychosis: The effects of labelling on public stigma in a undergraduate population.Early Interv Psychiatry. 2019 Aug;13(4):874-881. doi: 10.1111/eip.12691. Epub 2018 Jun 21. Early Interv Psychiatry. 2019. PMID: 29927070
-
A pilot study investigating the effect of the BEGIN psychoeducation intervention for people at clinical high risk for psychosis on emotional and stigma-related experiences.Early Interv Psychiatry. 2024 Dec;18(12):1055-1061. doi: 10.1111/eip.13602. Epub 2024 Jul 30. Early Interv Psychiatry. 2024. PMID: 39081014
-
Ethical and Epidemiological Dimensions of Labeling Psychosis Risk.AMA J Ethics. 2016 Jun 1;18(6):633-42. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606. AMA J Ethics. 2016. PMID: 27322997 Free PMC article. Review.
-
A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.Schizophr Res. 2020 Aug;222:104-112. doi: 10.1016/j.schres.2020.04.019. Epub 2020 Jun 7. Schizophr Res. 2020. PMID: 32522469 Free PMC article. Review.
Cited by
-
Language Matters: Exploring Preferred Terms for Diverse Populations.Glob Qual Nurs Res. 2024 Sep 3;11:23333936241275266. doi: 10.1177/23333936241275266. eCollection 2024 Jan-Dec. Glob Qual Nurs Res. 2024. PMID: 39233769 Free PMC article.
-
Validation of the Korean version of the 16-Item Prodromal Questionnaire in a Non-Help-Seeking College Population.Psychiatry Investig. 2018 Feb;15(2):111-117. doi: 10.30773/pi.2017.04.24. Epub 2017 Nov 29. Psychiatry Investig. 2018. PMID: 29475231 Free PMC article.
-
Positive Reframing of Psychosis Risk Is Seen as More Beneficial and Less Harmful Than Negative Framing by Clinicians: An Experimental Videotaped Simulated Feedback Study.Schizophr Bull. 2025 May 8;51(3):730-741. doi: 10.1093/schbul/sbae067. Schizophr Bull. 2025. PMID: 38727200 Free PMC article.
-
Stigma of ultra-high risk for psychosis: an updated systematic review.Braz J Psychiatry. 2024;46:e20233385. doi: 10.47626/1516-4446-2023-3385. Epub 2024 Jan 28. Braz J Psychiatry. 2024. PMID: 38281160 Free PMC article.
-
Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.Harv Rev Psychiatry. 2016 Mar-Apr;24(2):87-103. doi: 10.1097/HRP.0000000000000109. Harv Rev Psychiatry. 2016. PMID: 26954594 Free PMC article. Review.
References
-
- Angermeyer M, Matschinger H. The effect of diagnostic labelling on the lay theory regarding schizophrenic disorders. Social Psychiatry and Psychiatric Epidemiology. 1996;31(6):316–320. - PubMed
-
- Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. Journal of consulting and clinical psychology. 1988;56(6):893. - PubMed
-
- Beck AT, Ward C, Mendelson M. Beck depression inventory (BDI) Arch Gen Psychiatry. 1961;4(6):561–571. - PubMed
-
- Carpenter WT., Jr Conceptualizing schizophrenia through attenuated symptoms in the population. American Journal of Psychiatry. 2010;167(9):1013–1016. - PubMed
-
- Corcoran C, Kimhy D, Parrilla-Escobar M, Cressman V, Stanford A, Thompson J, David SB, Crumbley A, Schobel S, Moore H. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological medicine. 2011;41(02):251–261. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical